retatrutide mechanism triple agonist gip glp-1 glucagon receptor Agonists for Diabetes: Why May Be the Missing Piece Demonstrated metabolic effects of GIP,

Y.MeligyF

n = 47 mice per group for DA-GIP

While the medications seem to be effective in weight loss and treating type 2 diabetes, consumers report numerous side effects, including: Reduced appetite Diarrhea Bloating Nausea Vomiting Fatigue Constipation Indigestion Abdominal pain Patients using Ozempic, Wegovy, and Mounjaro have reported other, more severe, conditions

Months 36: This phase showed the most consistent weight reduction in trial data

HbA1c, , -1

Many practitioners start newer patients on the 600mg dose, then move to 1200mg for those wanting a stronger effect or continuing an existing treatment plan